Endocannabinoids and basal ganglia functionality

This publication has 100 references indexed in Scilit:

• Increased cannabinoid CB₁ receptor binding and activation of GTP‐binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP‐treated marmosets
  European Journal of Neuroscience, 2001
• Changes in cannabinoid CB₁ receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
  Synapse, 2001
• Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
  Biochemical and Biophysical Research Communications, 1999
• Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1, receptor ligand
  Life Sciences, 1996
• Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain
  FEBS Letters, 1995
• Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function
  Brain Research, 1995
• The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway
  Brain Research, 1995
• The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons
  Life Sciences, 1995
• Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatum
  Neuroscience Letters, 1992
• Delta-9-THC in the Treatment of Spasticity Associated with Multiple Sclerosis
  Advances in Alcohol & Substance Abuse, 1988